Did Frédéric Chopin Die From Heart Failure?

Abstract:

:On October 17, 1849, Poland's greatest composer, Frédéric Chopin (1810-1849) died aged 39. His cause of death remains unknown. An investigation of the documental sources was performed to reconstruct the medical history of the artist. Since his earliest years, his life had been dominated by poor health. Recurrent episodes of cough, fever, headaches, lymphadenopathy- a series of symptoms that may be attributed to viral respiratory infections- manifested in his teens. Later in life, he had chest pain, hemoptysis, hematemesis, neuralgia, and arthralgia. Exhaustion and breathlessness characterized all his adult life. Coughing, choking, and edema of the legs and ankles manifested four months before his death. Several hypotheses ranging from cystic fibrosis to alpha-1 anti-trypsin deficiency and pulmonary tuberculosis have been proposed to explain Chopin's lifelong illness. We suggest that Chopin had dilated cardiomyopathy with consequent heart failure and cirrhosis that caused his death.

journal_name

J Card Fail

authors

Perciaccante A,Charlier P,Negri C,Coralli A,Appenzeller O,Bianucci R

doi

10.1016/j.cardfail.2018.03.009

subject

Has Abstract

pub_date

2018-05-01 00:00:00

pages

342-344

issue

5

eissn

1071-9164

issn

1532-8414

pii

S1071-9164(18)30122-2

journal_volume

24

pub_type

传,历史文章
  • Relationship between anemia and health care costs in heart failure.

    abstract:BACKGROUND:Anemia is associated with higher morbidity and mortality in patients with heart failure (HF), but its implications for heath care costs are not well described. METHODS AND RESULTS:We analyzed data on 1056 patients with symptomatic HF seen at Duke University between 2002 and 2006. Health care costs were obta...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.06.435

    authors: Allen LA,Anstrom KJ,Horton JR,Shaw LK,Eisenstein EL,Felker GM

    更新日期:2009-12-01 00:00:00

  • Beta-blockers and inspiratory pulmonary function in chronic heart failure.

    abstract:BACKGROUND:Chronic heart failure (CHF) patients complain of breathlessness and fatigue. Respiratory muscle function is impaired in CHF patients and may contribute to their symptoms. Beta-blockers cause fatigue but have become part of the standard management of CHF. We explored the relation between respiratory muscle po...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2004.07.007

    authors: Witte KK,Clark AL

    更新日期:2005-03-01 00:00:00

  • Differences in education, knowledge, self-management activities, and health outcomes for patients with heart failure cared for under the chronic disease model: the improving chronic illness care evaluation.

    abstract:BACKGROUND:The objective of this study was to determine whether participation in a quality improvement (QI) collaborative for heart failure (HF) was associated with better interpersonal aspects of care and health outcomes. METHODS AND RESULTS:We conducted a cross-sectional telephone survey of patients in 6 organizatio...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2005.03.010

    authors: Baker DW,Asch SM,Keesey JW,Brown JA,Chan KS,Joyce G,Keeler EB

    更新日期:2005-08-01 00:00:00

  • Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long-Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

    abstract:BACKGROUND:Donor-transmitted atherosclerosis (DTA) and rapidly progressive cardiac allograft vasculopathy (CAV) at 1 year are intravascular ultrasound (IVUS)-derived measures shown to predict adverse cardiovascular outcomes in the setting of early generation immunosuppressive agents. Given the paucity of data on the pr...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.12.012

    authors: Sperry BW,Qarajeh R,Omer MA,Brandt H,Safley D,Borkon AM,Everley MP,Fendler TJ,Khumri TM,Lawhorn SL,Magalski A,Nassif ME,Vodnala D,Kao AC,Austin BA

    更新日期:2021-01-20 00:00:00

  • Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.

    abstract:BACKGROUND:Genetic heterogeneity at the endothelial nitric oxide synthase (NOS3) locus influences heart failure outcomes. The prevalence of NOS3 variants differs in black and white cohorts, but the impact of these differences is unknown. METHODS AND RESULTS:Subjects (n = 352) in the Genetic Risk Assessment of Heart Fa...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2008.10.028

    authors: McNamara DM,Tam SW,Sabolinski ML,Tobelmann P,Janosko K,Venkitachalam L,Ofili E,Yancy C,Feldman AM,Ghali JK,Taylor AL,Cohn JN,Worcel M

    更新日期:2009-04-01 00:00:00

  • Design of an acute dP/dt hemodynamic measurement protocol to isolate cardiac effect of pacing.

    abstract:BACKGROUND:Invasively measured maximum increase in left ventricular pressure (LV dP/dtmax) has been used to assess biventricular (BiV) pacing. We quantified extracardiac factors contributing to its variability, and developed a protocol to minimize these effects in an acute pacing experiment. METHODS AND RESULTS:Contin...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2014.01.020

    authors: Thibault B,Dubuc M,Karst E,Andrade J,Dyrda K,Guerra PG,Macle L,Rivard L,Roy D,Talajic M,Ryu K,Farazi TG,Varma N,Khairy P

    更新日期:2014-05-01 00:00:00

  • Risk Prediction Models for Incident Heart Failure: A Systematic Review of Methodology and Model Performance.

    abstract:BACKGROUND:Numerous models predicting the risk of incident heart failure (HF) have been developed; however, evidence of their methodological rigor and reporting remains unclear. This study critically appraises the methods underpinning incident HF risk prediction models. METHODS AND RESULTS:EMBASE and PubMed were searc...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2017.03.005

    authors: Sahle BW,Owen AJ,Chin KL,Reid CM

    更新日期:2017-09-01 00:00:00

  • Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.

    abstract:BACKGROUND:The aim of this study was to evaluate the effects of carvedilol therapy on left atrial (LA) function in patients with heart failure from nonischemic dilated cardiomyopathy. METHODS AND RESULTS:Thirty-five patients (42.4 +/- 13.5 years) in New York Heart Association functional Class II-III have been studied....

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.10.011

    authors: Paraskevaidis I,Farmakis D,Parissis JT,Dodouras T,Filippatos G,Tsiapras D,Kremastinos DT

    更新日期:2007-03-01 00:00:00

  • Airway resistance in chronic heart failure measured by impulse oscillometry.

    abstract:BACKGROUND:Patients with chronic heart failure (CHF) complain of breathlessness and fatigue on exertion, have reduced peak oxygen consumption (pV(O(2))), and an increased ventilatory response to exercise (V(E)/V(CO(2)) slope). These limitations correlate with abnormalities of spirometry (forced expiratory volume in 1 s...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2002.126916

    authors: Witte KK,Morice A,Clark AL,Cleland JG

    更新日期:2002-08-01 00:00:00

  • Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.

    abstract::Although atrial fibrillation is common in patients with heart failure, patients with atrial fibrillation are often excluded from congestive heart failure trials or are not analyzed separately. Consequently, while the effect of angiotensin-converting enzyme inhibitors in patients with sinus rhythm is well established, ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(05)80004-1

    authors: Van Den Berg MP,Crijns HJ,Van Veldhuisen DJ,Griep N,De Kam PJ,Lie KI

    更新日期:1995-12-01 00:00:00

  • Biomarker-guided therapies in heart failure: a forum for unified strategies.

    abstract::The complexity of standard medical treatment for heart failure is growing, and such therapy typically involves 5 or more different medications. Given these pressures, there is increasing interest in harnessing cardiovascular biomarkers for clinical application to more effectively guide diagnosis, risk stratification, ...

    journal_title:Journal of cardiac failure

    pub_type:

    doi:10.1016/j.cardfail.2013.05.012

    authors: Fiuzat M,O'Connor CM,Gueyffier F,Mascette AM,Geller NL,Mebazaa A,Voors AA,Adams KF,Piña IL,Neyses L,Muntendam P,Felker GM,Pitt B,Zannad F,Bristow MR

    更新日期:2013-08-01 00:00:00

  • A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure.

    abstract:BACKGROUND:We sought to systematically combine the evidence on efficacy of disease management programs (DMPs) in the treatment of congestive heart failure (CHF), to identify and explain heterogeneity of results from prior studies of DMPs, and to assess potential publication bias from these studies. METHODS AND RESULTS...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.cardfail.2006.03.003

    authors: Göhler A,Januzzi JL,Worrell SS,Osterziel KJ,Gazelle GS,Dietz R,Siebert U

    更新日期:2006-09-01 00:00:00

  • The role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditis.

    abstract:BACKGROUND:Idiopathic giant cell myocarditis (GCM) is an uncommon cause of cardiac failure distinguished clinically from lymphocytic myocarditis by rapidly progressive heart failure, arrhythmias, and heart block. Unlike fulminant lymphocytic myocarditis, patients with fulminant cardiac failure caused by GCM may respond...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2002.32196

    authors: Shields RC,Tazelaar HD,Berry GJ,Cooper LT Jr

    更新日期:2002-04-01 00:00:00

  • Acute Unloading Effects of Sildenafil Enhance Right Ventricular-Pulmonary Artery Coupling in Heart Failure.

    abstract:BACKGROUND:Phosphodiesterase-5A inhibitors (PDE5i) are sometimes used in patients with advanced heart failure with reduced ejection fraction before heart transplant or left ventricular assist device implantation to decrease right ventricular (RV) afterload and mitigate the risk of right heart failure. Conflicting evide...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.11.007

    authors: Monzo L,Reichenbach A,Al-Hiti H,Borlaug BA,Havlenova T,Solar N,Tupy M,Ters J,Kautzner J,Melenovsky V

    更新日期:2020-11-21 00:00:00

  • Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.

    abstract:BACKGROUND:Renal impairment is associated with increased mortality in heart failure (HF). Recently, reports suggest that worsening renal function (WRF) is another predictor of clinical outcome in HF. The present study was designed to establish the proportion of patients with HF that exhibits (WRF) and the associated ri...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.cardfail.2007.04.008

    authors: Damman K,Navis G,Voors AA,Asselbergs FW,Smilde TD,Cleland JG,van Veldhuisen DJ,Hillege HL

    更新日期:2007-10-01 00:00:00

  • Persistent anemia after implantation of the total artificial heart.

    abstract:BACKGROUND:The total artificial heart (TAH) replaces the heart with 2 pneumatic pumps and 4 tilting disk mechanical valves. It was hypothesized that patients receiving TAH support have persistent hemolysis that resolves after heart transplantation (HT). METHODS AND RESULTS:Hematocrit (HCT) was compared in patients on ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2012.03.003

    authors: Mankad AK,Tang DG,Clark WB,Flattery M,Harton S,Katlaps GJ,Stribling WK,Cooke RH,Hess ML,Kasirajan V,Shah KB

    更新日期:2012-06-01 00:00:00

  • Comparison of perfusion-metabolism mismatch in 99mTc-MIBI and 123I-BMIPP scintigraphy with cardiac magnetic resonance in patients with dilated cardiomyopathy.

    abstract:BACKGROUND:Cardiac magnetic resonance (CMR) imaging is an established method of detecting myocardial fibrosis related to prognosis in patients with dilated cardiomyopathy (DCM). Recent studies have found that (99m)Tc-methoxy-isobutyl-isonitrile (MIBI) and (123)I-15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid (BMIPP)...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2013.05.009

    authors: Yoshida A,Takano H,Asai K,Yasutake M,Amano Y,Kumita S,Shimizu W,Mizuno K

    更新日期:2013-07-01 00:00:00

  • Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial.

    abstract:INTRODUCTION:A major outcome determinant in patients with precapillary pulmonary hypertension (PH) is right ventricular (RV) function. We studied the effect of ranolazine on RV function over 6 months using cardiovascular magnetic resonance (CMR) imaging in patients with precapillary PH (groups I, III, and IV). METHODS...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.10.006

    authors: Han Y,Forfia P,Vaidya A,Mazurek JA,Park MH,Ramani G,Chan SY,Waxman AB

    更新日期:2020-10-24 00:00:00

  • Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes.

    abstract:BACKGROUND:Limited data exist on outcomes in patients ≥70 years of age supported with the use of continuous-flow left ventricular assist devices (LVADs). METHODS:Data on 1149 continuous-flow LVAD recipients was queried from the Mechanical Circulatory Support Research Network. Groups were assigned based on age: ≥70 yea...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2016.10.004

    authors: Kim JH,Singh R,Pagani FD,Desai SS,Haglund NA,Dunlay SM,Maltais S,Aaronson KD,Stulak JM,Davis ME,Salerno CT,Cowger JA,Shah P,Mechanical Circulatory Support Research Network (MCSRN).

    更新日期:2016-12-01 00:00:00

  • Prognosis of hospitalized new-onset systolic heart failure in Indo-Asians--a lethal problem.

    abstract:BACKGROUND:Systolic heart failure (SHF), particularly when requiring hospital admission carries a poor prognosis. There is a paucity of data in Indo-Asians on outcomes of SHF, among whom the burden of cardiovascular disease is consistently rising. The purpose of this study was to determine the frequency and predictors ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2007.07.005

    authors: Jafary FH,Kumar M,Chandna IE

    更新日期:2007-12-01 00:00:00

  • High-intensity interval exercise in chronic heart failure: protocol optimization.

    abstract:BACKGROUND:There are little data on the optimization of high-intensity aerobic interval exercise (HIIE) protocols in patients with chronic heart failure (CHF). Therefore, we compared acute cardiopulmonary responses to 4 different HIIE protocols to identify the optimal one. METHODS AND RESULTS:Twenty men with stable sy...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2011.10.010

    authors: Meyer P,Normandin E,Gayda M,Billon G,Guiraud T,Bosquet L,Fortier A,Juneau M,White M,Nigam A

    更新日期:2012-02-01 00:00:00

  • Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay.

    abstract:BACKGROUND:Little is known about guideline-directed pharmacotherapy use in patients with heart failure and reduced ejection fraction (HFrEF) discharged to skilled nursing facilities (SNFs). This study aimed to describe the use of angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blocker (ARBs) and e...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2017.09.007

    authors: Li L,Jesdale BM,Hume A,Gambassi G,Goldberg RJ,Lapane KL

    更新日期:2017-12-01 00:00:00

  • Right ventricular dysfunction and adverse outcome in patients with advanced heart failure.

    abstract:BACKGROUND:In patients with heart failure (HF) from left ventricular systolic dysfunction, the presence of coexistent right ventricular (RV) dysfunction is associated with poor exercise capacity and reduced survival. We sought to determine whether a simple measure of RV function, the RV myocardial performance index (RV...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.06.472

    authors: Field ME,Solomon SD,Lewis EF,Kramer DB,Baughman KL,Stevenson LW,Tedrow UB

    更新日期:2006-10-01 00:00:00

  • Effects of glucocorticoids in potentiating diuresis in heart failure patients with diuretic resistance.

    abstract::Diuretic resistance in heart failure is defined as a state in which diuretic response is diminished or lost before the therapeutic goal of relief from congestion has been reached. Diuretic resistance is very common and is associated with poor outcomes. Over the past decade, several new drugs and devices targeting deco...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/j.cardfail.2014.06.353

    authors: Liu C,Liu K

    更新日期:2014-09-01 00:00:00

  • Cardiovascular Magnetic Resonance May Avoid Unnecessary Coronary Angiography in Patients With Unexplained Left Ventricular Systolic Dysfunction: A Retrospective Diagnostic Pilot Study.

    abstract:BACKGROUND:Coronary angiography (CA) is usually performed in patients with reduced left ventricular ejection fraction (LVEF) to search ischemic cardiomyopathy. Our aim was to examine the agreement between CA and cardiovascular magnetic resonance (CMR) imaging among a cohort of patients with unexplained reduced LVEF, an...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.09.005

    authors: Desroche LM,Milleron O,Safar B,Ou P,Garbarz E,Lavie-Badie Y,Abtan J,Millischer D,Pathak A,Durand-Zaleski I,Cattan S,Ronchard T,Jondeau G

    更新日期:2020-12-01 00:00:00

  • Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

    abstract:BACKGROUND:Heart failure in blacks has been associated with a poorer prognosis than in whites. In such diseases as hypertension, blacks show pathophysiological differences and respond differently to some therapies than whites. The aim of this study is to evaluate the clinical characteristics and response to therapy of ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(99)90001-5

    authors: Carson P,Ziesche S,Johnson G,Cohn JN

    更新日期:1999-09-01 00:00:00

  • Genetic testing for dilated cardiomyopathy in clinical practice.

    abstract:BACKGROUND:Familial involvement is common in dilated cardiomyopathy (DCM) and >40 genes have been implicated in causing disease. However, the role of genetic testing in clinical practice is not well defined. We examined the experience of clinical genetic testing in a diverse DCM population to characterize the prevalenc...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2012.01.013

    authors: Lakdawala NK,Funke BH,Baxter S,Cirino AL,Roberts AE,Judge DP,Johnson N,Mendelsohn NJ,Morel C,Care M,Chung WK,Jones C,Psychogios A,Duffy E,Rehm HL,White E,Seidman JG,Seidman CE,Ho CY

    更新日期:2012-04-01 00:00:00

  • Validation of a risk score for dying within 1 year of an admission for heart failure.

    abstract:BACKGROUND:Development of heart failure greatly reduces life expectancy. Accurate estimates of the risk of dying are needed in clinical practice and for risk adjustment in observational studies. A relatively simple risk score has been developed to determine the risk of dying within 1-year of an admission for heart fail...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.02.004

    authors: Rector TS,Ringwala SN,Ringwala SN,Anand IS

    更新日期:2006-05-01 00:00:00

  • The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.

    abstract::Propionyl-L-carnitine (PLC) is a naturally occurring compound that has been considered for the treatment of congestive heart failure (CHF). The rationale for its use in this pathology is related to its effects on cardiac and skeletal muscle. Chronic treatment with PLC improves the contraction of isolated and aerobic p...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/s1071-9164(97)90018-x

    authors: Ferrari R,De Giuli F

    更新日期:1997-09-01 00:00:00

  • Comparison of direct body composition assessment methods in patients with chronic heart failure.

    abstract:BACKGROUND:We examined the validity of leg-to-leg bioelectrical impedance analysis (BIA) and near-infrared interactance (NIR) to assess body composition in chronic heart failure (CHF) patients. METHODS AND RESULTS:A total of 140 patients with CHF were enrolled in this cross-sectional study between June 2008 and July 2...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.06.416

    authors: Oreopoulos A,Kalantar-Zadeh K,McAlister FA,Ezekowitz JA,Fonarow GC,Johnson JA,Norris CM,Padwal RS

    更新日期:2010-11-01 00:00:00